Reyon Pharmaceutical Co (XKRX:102460) Net Change in Cash : ₩-13,898 Mil (TTM As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Reyon Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Reyon Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2025 was ₩0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-13,898 Mil.

Reyon Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Reyon Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reyon Pharmaceutical Co Net Change in Cash Chart

Reyon Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

6,371.19

54,544.33

-50,691.42

8,057.79

-13,898.13

Reyon Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-6,881.48	-9,341.34	-1,466.11	3,790.80	-

Reyon Pharmaceutical Co Net Change in Cash Calculation

Reyon Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-1435.814	+	-16590.826	+	4128.295	+	0.213
	=	-13,898

Reyon Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0 + 0 + 0 + 0

= 0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-13,898 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reyon Pharmaceutical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Reyon Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Reyon Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Reyon Pharmaceutical Co Ltd (XKRX:102460) » Definitions » Net Change in Cash

Comparable Companies

XKRX:096760 XKRX:001630 XKRX:005500 XKRX:293480 XKRX:007570 XKRX:092040 XKRX:293780 XKRX:271980 XKRX:016580 XKRX:234080 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

416, Yeongdong-daero, 8th floor, Gangnam-gu, Seoul, KOR

Website

http://reyonpharm.co.kr

Reyon Pharmaceutical Co Ltd is a Korea-based pharmaceutical company. It is engaged in the manufacturing and distribution of specialty medicines and raw materials. The main business of the company has been divided into generic drugs, original drugs, and drug substances The key products include eye drops, injection, antibiotics, skeletal muscle relaxants, coagulation drugs, anti-inflammatory enzymes, and blood vessels dialectic drugs, among others.

Reyon Pharmaceutical Co Headlines

No Headlines